The Value of Peripheral Blood Lymphocyte Subsets in Predicting Immune Checkpoint Inhibitor Related Adverse Events in Lung Cancer Patients

HUANG Aiben, LIU Jia, ZHANG Duchao, PANG Li, XIE Mei, MA Xidong, MA Xiaorong, ZHANG Zhenning, QIAN Jin, JIANG Hong, XUE Xinxin, PAN Lei

PDF(1028 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1028 KB)
Labeled Immunoassays and Clinical Medicine ›› 2025, Vol. 32 ›› Issue (5) : 889-893. DOI: 10.11748/bjmy.issn.1006-1703.2025.05.003
Clinical Investigation

The Value of Peripheral Blood Lymphocyte Subsets in Predicting Immune Checkpoint Inhibitor Related Adverse Events in Lung Cancer Patients

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 32(5): 889-893 https://doi.org/10.11748/bjmy.issn.1006-1703.2025.05.003

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1028 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉